Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects

Endometriosis is a chronic pain condition affecting 1 in 10 women. There is an unmet need for better medical treatments for endometriosis. We spotlight trials of a single preparation combined HRT-GnRH antagonist (Relugolix) by Giudice et al.,(1) for endometriosis-associated pain.

Detalles Bibliográficos
Autores principales: Whitaker, L.H.R., Saraswat, L., Horne, A.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Spotlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512692/
https://www.ncbi.nlm.nih.gov/pubmed/36130483
http://dx.doi.org/10.1016/j.xcrm.2022.100748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512692/
https://www.ncbi.nlm.nih.gov/pubmed/36130483
http://dx.doi.org/10.1016/j.xcrm.2022.100748

Ejemplares similares